Rose-John, Stefan
Winthrop, Kevin
Calabrese, Leonard
Article History
First Online: 15 June 2017
Competing interests
: L.H.C. declares that he has acted as a consultant for Bristol–Myers Squib, Genentech-Roche, Jansen, Pfizer, Regeneron, Sanofi-Aventis and UCB, and has acted as a speaker for Bristol–Myers Squib, Genentech, Jansen and UCB. S.R.-J. has acted as a consultant and speaker for AbbVie, Chugai, Genentech Roche, Pfizer and Sanofi. He also declares that he is an inventor on patents owned by CONARIS Research Institute, which develops the sgp130Fc protein olamkicept together with Ferring Pharmaceuticals and he has stock ownership in CONARIS. K.W. declares that he has acted as a consultant to AbbVie, Bristol–Myers Squib, Genentech-Roche, Lilly, Pfizer and UCB, and received a research grant from Bristol–Myers Squib.